Royal Bank of Canada
IRD

Royal Bank of Canada’s Opus Genetics IRD Stock Holding History

Royal Bank of Canada’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Sell
5
-294
-98% -$1.02K ﹤0.01% 7841
2025
Q4 		$1K Buy
299
+269
+897% +$546 ﹤0.01% 7085
2025
Q3 		$0 Sell
30
-127,220
-100% -$158K ﹤0.01% 7632
2025
Q2 		$120K Sell
127,250
-176,873
-58% -$164K ﹤0.01% 5524
2025
Q1 		$299K Buy
304,123
+304,096
+1,126,281% +$340K ﹤0.01% 4398
2024
Q4 		$0 Buy
27
+22
+440% +$25 ﹤0.01% 7348
2024
Q3 		$0 Sell
5
-21,940
-100% -$33.8K ﹤0.01% 7596
2024
Q2 		$34K Buy
21,945
+21,940
+438,800% +$37.9K ﹤0.01% 5838
2024
Q1 		$0 Sell
5
-15,631
-100% -$39.6K ﹤0.01% 7716
2023
Q4 		$47K Buy
15,636
+231
+1% +$683 ﹤0.01% 6027
2023
Q3 		$52K Sell
15,405
-6,000
-28% -$24.1K ﹤0.01% 5766
2023
Q2 		$93K Buy
21,405
+21,400
+428,000% +$102K ﹤0.01% 5400
2023
Q1 		$0 Hold
5
– – ﹤0.01% 7582
2022
Q4 		$0 Hold
5
– – ﹤0.01% 7821
2022
Q3 		$0 Hold
5
– – ﹤0.01% 7961
2022
Q2 		$0 Hold
5
– – ﹤0.01% 7795
2022
Q1 		$0 Hold
5
– – ﹤0.01% 8093
2021
Q4 		$0 Hold
5
– – ﹤0.01% 7950
2021
Q3 		$0 Hold
5
– – ﹤0.01% 7924
2021
Q2 		$0 Hold
5
– – ﹤0.01% 7738
2021
Q1 		$0 Hold
5
– – ﹤0.01% 7754
2020
Q4 		$0 Hold
5
– – ﹤0.01% 7336
2020
Q3 		$0 Hold
5
– – ﹤0.01% 6986
2020
Q2 		$0 Hold
5
– – ﹤0.01% 6961
2020
Q1 		$0 Hold
5
– – ﹤0.01% 7098
2019
Q4 		$0 Hold
5
– – ﹤0.01% 7188
2019
Q3 		$0 Sell
5
-26
-84% -$362 ﹤0.01% 7211
2019
Q2 		$1K Buy
31
+22
+244% +$497 ﹤0.01% 6757
2019
Q1 		$0 Hold
9
– – ﹤0.01% 7166
2018
Q4 		$0 Sell
9
-2
-18% -$117 ﹤0.01% 7180
2018
Q3 		$0 Hold
11
– – ﹤0.01% 6994
2018
Q2 		$0 Buy
11
+2
+22% +$176 ﹤0.01% 6820
2018
Q1 		$0 Sell
9
-3
-25% -$272 ﹤0.01% 6865
2017
Q4 		$2K Hold
12
– – ﹤0.01% 6308
2017
Q3 		$2K Sell
12
-4
-25% -$431 ﹤0.01% 6572
2017
Q2 		$2K Buy
16
+6
+60% +$1.17K ﹤0.01% 6299
2017
Q1 		$2K Buy
10
+2
+25% +$259 ﹤0.01% 6444
2016
Q4 		$0 Sell
8
-3
-27% -$244 ﹤0.01% 6813
2016
Q3 		$1K Hold
11
– – ﹤0.01% 6315
2016
Q2 		$2K Buy
11
+4
+57% +$561 ﹤0.01% 6166
2016
Q1 		$1K Buy
7
+4
+133% +$666 ﹤0.01% 6243
2015
Q4 		$1K Hold
3
– – ﹤0.01% 6502
2015
Q3 		$1K Hold
3
– – ﹤0.01% 6521
2015
Q2 		$1K Hold
3
– – ﹤0.01% 6476
2015
Q1 		$1K Buy
3
+1
+50% +$363 ﹤0.01% 6003
2014
Q4 		$1K Hold
2
– – ﹤0.01% 6060
2014
Q3 		$1K Sell
2
-2
-50% -$720 ﹤0.01% 5882
2014
Q2 		$2K Buy
+4
New +$1.82K ﹤0.01% 5737
2014
Q1 		– Sell
-9
Closed -$2K – 6189
2013
Q4 		$2K Buy
9
+4
+80% +$845 ﹤0.01% 5775
2013
Q3 		$1K Hold
5
– – ﹤0.01% 5976
2013
Q2 		$1K Buy
+5
New +$858 ﹤0.01% 5738

Other funds holding IRD

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Royal Bank of Canada's IRD Position: Q1 2026 in Review

Royal Bank of Canada reduced its Opus Genetics (IRD) stake by 98% in Q1 2026, selling an estimated $1.02K and leaving 5 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7841.

Royal Bank of Canada first reported a position in IRD in Q2 2013 and has held it in 51 quarters since. The position peaked at $299K in Q1 2025. 79 funds tracked by Wall St. Rank hold IRD as of Q1 2026.

  • Royal Bank of Canada held 5 shares of Opus Genetics worth $0 as of Q1 2026.
  • Royal Bank of Canada sold 294 Opus Genetics shares in Q1 2026, an estimated $1.02K.
  • Opus Genetics made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #7841 holding.
  • Royal Bank of Canada first reported a position in Opus Genetics in Q2 2013 and has held it in 51 quarters since.
  • Royal Bank of Canada's Opus Genetics position peaked at $299K in Q1 2025.
  • 79 funds tracked by Wall St. Rank held Opus Genetics as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.